4,828 Shares in Maximus, Inc. (NYSE:MMS) Purchased by Lingohr Asset Management GmbH

Lingohr Asset Management GmbH purchased a new stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 4,828 shares of the health services provider's stock, valued at approximately $358,000.

A number of other hedge funds have also bought and sold shares of MMS. Geode Capital Management LLC increased its position in shares of Maximus by 1.4% in the 3rd quarter. Geode Capital Management LLC now owns 1,525,159 shares of the health services provider's stock valued at $142,109,000 after acquiring an additional 21,532 shares during the period. Van Berkom & Associates Inc. increased its holdings in shares of Maximus by 8.5% in the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after purchasing an additional 98,264 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of Maximus by 7.7% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider's stock valued at $74,700,000 after purchasing an additional 71,598 shares during the period. Allspring Global Investments Holdings LLC raised its stake in shares of Maximus by 2.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider's stock worth $54,748,000 after purchasing an additional 16,772 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Maximus by 8.2% during the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider's stock worth $42,606,000 after purchasing an additional 43,421 shares during the period. Institutional investors and hedge funds own 97.21% of the company's stock.

Remove Ads

Maximus Stock Performance

Shares of NYSE MMS traded down $0.76 during trading on Monday, reaching $66.48. 606,984 shares of the company traded hands, compared to its average volume of 491,334. The stock has a market cap of $3.76 billion, a P/E ratio of 14.30 and a beta of 0.71. The firm's fifty day simple moving average is $70.86 and its 200 day simple moving average is $78.31. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. As a group, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Saturday, February 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend was Friday, February 14th. Maximus's dividend payout ratio is currently 25.81%.

Analyst Ratings Changes

Several equities analysts recently weighed in on the stock. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price target on the stock in a report on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research note on Friday, February 14th.

Insider Buying and Selling

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total transaction of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the firm's stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.